Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/9227
Title: O-glycosylation delays the clearance of human IGF-binding protein-6 from the circulation.
Austin Authors: Marinaro, J A;Casley, David J;Bach, Leon A
Affiliation: Department of Medicine, Austin and Repatriation Medical Centre, University of Melbourne, Heidelberg, Victoria 3084, Australia
Issue Date: 1-May-2000
Publication information: European Journal of Endocrinology / European Federation of Endocrine Societies; 142(5): 512-6
Abstract: The actions of insulin-like growth factors (IGF-I and IGF-II) are modulated by a family of six structurally related, high-affinity binding proteins (IGFBPs 1-6). IGFBP-6, an O-linked glycoprotein, preferentially binds IGF-II and inhibits its actions. The aim of this study was to investigate whether O-glycosylation modulates the pharmacokinetics of IGFBP-6.The pharmacokinetic profiles of (125)I-labelled glycosylated (g) and non-glycosylated (n-g) recombinant human IGFBP-6 were studied following intravenous bolus administration in anaesthetised rats.The redistribution half-life of gIGFBP-6 was 2.3-fold greater than that of n-gIGFBP-6 (14.4+/- 1.2 vs 6.3+/-1.5 min, P=0. 006). The elimination half-life of gIGFBP-6 was 21-fold greater than that of n-gIGFBP-6 (584.2+/-130.2 vs 28.0+/-4.2 min, P=0.019). The effect of O-glycosylation on IGFBP-6 pharmacokinetics was not due to inhibition of intravascular proteolysis. Radioactivity was found in stomach, kidneys, lung, spleen, heart and liver but not brain 4h after injection of g or n-gIGFBP-6.O-glycosylation delays the clearance of IGFBP-6 from the circulation and may therefore contribute to its role as a circulating inhibitor of IGF-II actions.
Gov't Doc #: 10802531
URI: https://ahro.austin.org.au/austinjspui/handle/1/9227
Journal: European journal of endocrinology / European Federation of Endocrine Societies
URL: https://pubmed.ncbi.nlm.nih.gov/10802531
Type: Journal Article
Subjects: Animals
Glycosylation
Half-Life
Humans
Injections, Intravenous
Insulin-Like Growth Factor Binding Protein 6.administration & dosage.metabolism.pharmacokinetics
Iodine Radioisotopes.diagnostic use
Male
Rats
Rats, Sprague-Dawley
Recombinant Proteins.administration & dosage.metabolism.pharmacokinetics
Tissue Distribution
Appears in Collections:Journal articles

Show full item record

Page view(s)

20
checked on Dec 10, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.